Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
Experts have expressed concerns that disruptions to treatment will allow the bacteria to further mutate to new, untreatable ...
"These districts have surpassed 100 per cent screening coverage among vulnerable populations," said Dr A Rajesham, Joint ...
Tuberculosis surveillance and monitoring report, released today by the European Centre for Disease Prevention and Control ...
The Conversation on MSN7d
Tuberculosis was once a disease in decline, but a resurgence in cases has health officials puzzledTuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...
World Tuberculosis Day 2025 is observed on March 24 to raise awareness about the bacterial disease and its effects on the ...
Underlining the new innovations rolled out under the programme, Patel stated that ICMR has validated three indigenous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback